Assessing FMC (FMC) Valuation After EU Approval For Isoflex Active Herbicide
FMC recently received EU approval for its new Isoflex active herbicide, which could open significant commercialization opportunities starting in 2027. Despite a strong recent rebound in its stock price, the company's valuation still shows a 27.4% intrinsic discount, making investors question if the market has fully priced in this potential growth. The current narrative suggests FMC is 5% undervalued at $18.12, driven by expected margin improvements and cash flow repairs, but risks like regulatory scrutiny and pricing pressure could impact future margins.
FMC secures E.U. approval for Isoflex herbicide active ingredient (FMC:NYSE)
FMC Corporation announced that its herbicide active ingredient, bixlozone (marketed as Isoflex active), has received regulatory approval in the European Union. This approval is a significant step for the product's commercialization. Following the announcement, FMC's stock saw a slight increase in after-hours trading.
FMC's Isoflex®active Receives EU Regulatory Approval
FMC Corporation has received regulatory approval in the EU for its herbicide Isoflex®active (bixlozone), allowing product launches across over 55 million hectares of various crops starting in 2027. This approval addresses a critical gap in the European agricultural market after the loss of multiple active ingredients and strengthens FMC's competitive position. Isoflex®active has already been successfully rolled out in other countries, and FMC continues R&D efforts for its use in additional crops.
FMC Corp. announced that its Isoflex® active ingredient has successfully received approval from European Union regulators.
FMC Corp. has announced that its Isoflex® active ingredient has received approval from European Union regulators. This development addresses a significant gap in the European herbicide market and represents a strategic breakthrough for FMC in Europe, promising more effective weed control solutions for agriculture.
EU growers lost 20+ herbicide actives. FMC’s new option is approved
FMC Corporation has received EU regulatory approval for its Isoflex® active (bixlozone) herbicide, addressing a critical gap in the European herbicide market after growers lost access to over 20 active ingredients since 2019. The approval paves the way for product launches beginning in 2027, targeting more than 55 million hectares of cereals, corn, oilseed rape, and potato. Isoflex® active offers a new mode of action (HRAC Group 13) to combat resistant weeds, building on successful registrations and commercialization in several other countries.
FMC Corp. stock underperforms Monday when compared to competitors
FMC Corp. (FMC) stock dropped 3.04% on Monday, closing at $17.21. This underperformance occurred despite a positive trading session for the broader market, with both the S&P 500 and Dow Jones Industrial Average seeing gains. The company's stock is currently 61.57% below its 52-week high of $44.78, achieved on June 10th.
FMC (NYSE:FMC) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded FMC (NYSE:FMC) from a "sell" to a "hold" rating, though the consensus among analysts remains cautious with an average "Reduce" rating and a target price of $19.59. The company recently missed earnings expectations and reported a negative net margin. Despite a director's recent stock purchase, institutional ownership stands at over 91%, with the stock trading near $17.72.
SG Americas Securities LLC Acquires 102,545 Shares of FMC Corporation $FMC
SG Americas Securities LLC significantly increased its stake in FMC Corporation by 104.9%, acquiring an additional 102,545 shares to bring its total holdings to 200,326 shares, valued at approximately $2.78 million. This comes as Wall Street sentiment towards FMC has recently turned negative, with several analysts downgrading the stock and lowering price targets, resulting in a consensus "Reduce" rating. Additionally, FMC Director Michael F. Barry also increased his personal holdings in the company by over 1,100%, purchasing 18,072 shares for about $249,936.
FMC Corp stock: Why it's still a key player in agriculture amid challenges
FMC Corp is a significant player in the agricultural sciences sector, supplying crop protection solutions globally. The article highlights its market position, competitive edge through innovation and sustainability, and financial health, making it a defensive play for North American investors despite industry challenges like weather uncertainties and regulatory scrutiny. It also discusses analyst perspectives and key factors for investors to monitor.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 3.50% to $17.75 on Thursday, outperforming the S&P 500 Index and the Dow Jones Industrial Average, which saw mixed trading. Despite the daily gain, the company's stock remains significantly below its 52-week high, trading 60.36% lower than its peak of $44.78 reached on June 10th.
Top FMC (FMC) Competitors 2026
This article analyzes FMC (NYSE: FMC) and its main competitors in the diversified chemicals industry, comparing them across various financial metrics, analyst ratings, and media sentiment. The report identifies Olin (OLN), Huntsman (HUN), Lsb Industries (LXU), DOW (DOW), and PPG Industries (PPG) as key rivals. Each comparison evaluates factors such as profitability, risk, valuation, dividends, institutional ownership, and media perception to determine which company exhibits a stronger financial profile or better investment prospects.
FMC Corp. Stock: Navigating Agricultural Challenges and Recovery Opportunities in 2026
FMC Corp. (ISIN: US3024913036) faces agricultural market volatility linked to patent pressures and supply shifts. This analysis explores its business fundamentals, market position, and recovery potential for North American investors. The company focuses on crop protection, with a strong presence in North and South America, innovating in biopesticides and precision agriculture, thereby aligning with sustainable farming trends. Despite challenges like regulatory hurdles and commodity price swings, its upcoming Q1 2026 earnings will offer crucial insights into sales, margins, and strategic direction, positioning it as a key agricultural sector stock.
FMC Corporation (FMC) latest stock news and headlines
This article provides a compilation of recent news and headlines concerning FMC Corporation (FMC), including updates on stock performance, upcoming earnings calls, and analyst valuations. It highlights the company's stock movements, dividend declarations, and strategic announcements, offering investors a snapshot of its recent activities and market sentiment.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 6.66% to $16.81 on Monday, marking its sixth consecutive day of gains. This performance outpaced a mixed trading session where the Dow Jones Industrial Average saw a slight gain, and the S&P 500 Index experienced a decline. The article highlights the company's strong trading day relative to broader market trends.
FMC Corp (FMC) Climbs 6.66% Ahead of Dividends, Earnings
FMC Corporation (FMC) saw its stock rise by 6.66% to $16.81, marking its seventh consecutive day of gains. This surge occurred as investors bought shares in anticipation of its upcoming dividend payment of 8 cents per share and ahead of its first-quarter earnings release. The company projects Q1 revenues between $725 million and $775 million and full-year 2026 revenues of $3.6 billion to $3.8 billion, both showing a 5% decrease year-on-year, while adjusted EBITDA is expected to decline by 17% for the full year.
FMC Corporation Declares Quarterly Dividend of $0.08 (NYSE:FMC)
FMC Corporation declared a quarterly dividend of $0.08 per share, payable on April 16 to shareholders of record on March 31. Despite dividend consistency and a low payout ratio of 8%, the company recently missed quarterly EPS and revenue estimates, provided weak guidance, and faces trimmed analyst targets. The stock trades near $15.74 with a market cap of $1.97 billion, and analysts currently hold a "Reduce" consensus rating with an average price target of $19.59.
FMC (NYSE:FMC) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded FMC (NYSE:FMC) from "hold" to "sell," with MarketBeat's consensus rating now being "Reduce" and a target price of $19.59. This follows mixed Q4 2025 earnings where the company missed revenue estimates, reported a negative net margin, and provided weak EPS guidance for 2026. Despite the bearish sentiment from analysts, an insider, Michael F. Barry, recently purchased a significant amount of FMC stock, increasing his stake by over 1,100%.
FMC SEC Filings - Fmc Corp 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to FMC Corporation's SEC filings, including 10-K, 10-Q, and 8-K reports, vital for investors tracking the agricultural sciences company's financial and strategic developments. It details how the company uses these filings to disclose financial condition, restructuring activities, and governance, enhanced with AI-powered summaries for easier interpretation. Recent filings highlight director stock acquisitions through dividend equivalents and significant corporate actions like Project Foundation for cost optimization and amendments to credit agreements.
FMC SEC Filings - Fmc Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for FMC Corporation's SEC filings, including 10-K, 10-Q, and 8-K reports, crucial for investors monitoring the company's financial health, governance, and strategic initiatives. It details how FMC, a global agricultural sciences company, uses these filings to disclose financial conditions, restructuring efforts, and capital structure, with AI-powered summaries to simplify complex information. The page also lists recent insider trading activities from July 2025 with detailed explanations for each transaction, highlighting routine share issuances as dividend-equivalent rights.
Vanguard disaggregates holdings after realignment — FMC (NYSE: FMC) shows 0 ownership
The Vanguard Group filed a Schedule 13G/A amendment reporting 0 beneficial ownership of FMC Corp (NYSE: FMC) common stock. This change is due to an internal realignment on January 12, 2026, where certain Vanguard subsidiaries will now report ownership separately, as per SEC Release No. 34-39538. The filing clarifies a procedural change in reporting structure rather than a market transaction or change in company ownership levels.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) shares rose 1.42% to $15.66 on a Thursday when the broader market, including the S&P 500 Index and Dow Jones Industrial Average, experienced declines. This marks the fourth consecutive day of gains for the agricultural sciences company's stock. The article highlights FMC Corp.'s strong performance relative to its competitors during a generally grim trading session.
FMC Corp. Stock: Navigating Challenges in Agricultural Chemicals Amid Strategic Shifts and Market Pr
FMC Corp., a key player in agricultural chemicals, faces revenue declines and profitability pressures due to weak demand and patent losses. The company is actively pursuing strategic adjustments, including debt reduction through asset sales and licensing deals, and focusing on new product development. Investors are watching for signs of recovery, particularly with the upcoming Q1 2026 earnings release in April.
FMC Corp. Stock: Navigating Challenges in Agricultural Chemicals Amid Strategic Shifts and Market Pressures
FMC Corp., a leading agricultural sciences company, is facing revenue declines and profitability pressures due to weak demand and patent losses. The company is implementing strategic shifts, including debt reduction initiatives and exploring asset sales, to adapt to market challenges and regain growth. Investors are looking to upcoming Q1 2026 earnings and the progress of its restructuring efforts as key indicators for its recovery potential.
FMC Corp. stock faces pressure amid agricultural chemical sector slowdown and shifting demand patter
FMC Corp. stock is facing pressure due to a slowdown in the agricultural chemical sector, marked by weakening crop protection demand and farmers delaying purchases, affecting its Q1 guidance. The company is navigating challenges like volatile commodity inputs, inventory destocking, and high farmer inventories. Despite these headwinds, FMC is strategically shifting its portfolio towards high-growth areas like biologicals and precision agriculture while maintaining pricing power and appealing to investors with its dividend stability and lithium production growth.
Fitch revises FMC outlook on leverage concerns
Fitch Ratings has revised its outlook for FMC Corporation to Negative from Stable, affirming its Long-Term Issuer Default Rating at 'BB+'. The change reflects concerns that FMC's EBITDA leverage could exceed 4.5x, driven by increased generic competition, lower EBITDA, and negative free cash flow. Despite these challenges, Fitch acknowledges FMC's efforts to reduce debt through manufacturing restructuring and dividend cuts, supported by its strong position as a global crop protection company.
FMC Corp. stock outperforms competitors on strong trading day
Shares of FMC Corp. (FMC) rose 4.11% to $15.44 on Wednesday, outperforming the broader market. The S&P 500 Index gained 0.54% and the Dow Jones Industrial Average rose 0.66% during the same trading session. This marked the third consecutive day of gains for FMC Corp. stock.
FMC Corporation Announces Date for First Quarter 2026 Earnings Release and Webcast Conference Call
FMC Corporation has announced that it will release its first quarter 2026 earnings after the close of the New York Stock Exchange on Monday, May 4, 2026. The company will also host a webcast conference call on Tuesday, May 5, 2026, at 9:00 a.m. EDT, where President and CEO Mark Douglas and EVP and CFO Andrew Sandifer will discuss the company's financial results and outlook. Investors can access the webcast and presentation slides through the company's website.
FMC Corp. Hits Day High with 8.71% Surge in Strong Intraday Performance
FMC Corp., a small-cap company in the Chemicals & Petrochemicals sector, saw its stock surge by 8.71% to an intraday high of USD 14.56. While the company has outperformed the S&P 500 in the short term (past week and month), its shares have significantly declined by 65.72% over the last year. FMC Corp. has a market capitalization of USD 2,543 million and offers an 8.93% dividend yield.
FMC Corporation announces date for first quarter 2026 earnings release and webcast conference call
FMC Corporation (NYSE: FMC) will release its first-quarter 2026 earnings on Wednesday, April 29, 2026, after the stock market closes. The company will also host a public webcast conference call on Thursday, April 30, 2026, at 9:00 a.m. ET to discuss these results. Details for accessing the webcast and conference call are provided in the announcement.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) stock rose 4.22% to $14.83 on Tuesday, outperforming the broader market downturn as both the S&P 500 Index and Dow Jones Industrial Average fell. This marks the second consecutive day of gains for the company's stock. The article highlights FMC Corp.'s strong performance despite a negative overall trading session.
FMC Corporation announces date for first quarter 2026 earnings release and webcast conference call
FMC Corporation announced it will release its first quarter 2026 earnings on Wednesday, April 29, 2026, after the stock market closes. The company will also host a webcast conference call on Thursday, April 30, 2026, at 9:00 a.m. ET to discuss the results. Details for accessing the webcast and conference call are provided.
Citi Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $15
Citi analyst Patrick Cunningham has reiterated a "Hold" rating for FMC Corp (FMC.US) but has lowered the target price from $16 to $15. This adjustment is based on the analyst's past performance, which shows a 50.3% success rate and a 4.2% average return over the last year, according to TipRanks data. TipRanks provides independent analysis of financial analysts' recommendations, evaluating their success rates and average returns.
FMC Corp Stock Jumps on Strategic Sale Exploration Amid Ag Chem Sector Pressures
FMC Corporation is exploring strategic alternatives, including a potential sale, which has caused its stock to jump amid pressures in the agricultural chemicals sector. The company faces declining revenues, significant debt, and broader industry challenges, but a potential takeover could unlock value for investors. Analysts suggest a significant upside from current stock levels, despite near-term volatility and negative Q1 EPS guidance.
FMC Corp. stock outperforms competitors on strong trading day
FMC Corp. (FMC) shares rose 8.71% to $14.23 on Monday, outperforming the broader market indexes like the S&P 500 and Dow Jones Industrial Average. This increase ended a two-day losing streak for the stock. The article highlights the stock's strong performance on a positive trading day.
FMC Corp. stock faces pressure amid agricultural chemical demand slowdown and trade tensions
FMC Corp. is struggling with reduced demand in the agricultural chemical market due to lower commodity prices and favorable weather. The company's stock has faced downward pressure, with preliminary Q1 results showing lower-than-expected volumes. Despite a strong balance sheet and focus on biologicals, FMC faces risks from trade tensions, regulatory hurdles, and intense competition, making investor patience crucial amidst macro uncertainties.
FMC Shares Plummet, Investors Face Challenges
FMC Corporation's shares have plummeted by approximately two-thirds over the past year due to severe challenges in the agricultural chemicals sector, poor financial performance, and strategic adjustments including an 86% dividend cut. Revenue for 2024 is reported at $4.2 billion, with an expected 8% decline in 2025, alongside drops in adjusted EBITDA and EPS, signaling a decline in profitability from weak demand and patent expirations. While the company is exploring strategic alternatives like a potential sale, new patented crop protection products could act as future catalysts, though their market impact may take years to materialize.
FMC Corp. stock underperforms Friday when compared to competitors
FMC Corp. (FMC) stock decreased by 6.03% to $13.09 on Friday, marking its second consecutive day of losses. This underperformance occurred during a generally negative trading session, with the S&P 500 Index (SPX) falling 1.51% and the Dow Jones Industrial Average (DJIA) falling 0.96%.
A Look At FMC (FMC) Valuation As Governance Reforms Shift Shareholder Rights
FMC (FMC) is proposing governance changes, including removing supermajority voting and allowing investors with 25% ownership to call special meetings, ahead of its April 28, 2026 annual meeting. These changes come after a significant 65.33% decline in shareholder return over the past year, though the stock is currently trading at a reported 32% discount to one intrinsic value estimate of $18.12 per share. The company's valuation narrative suggests it is undervalued, supported by ongoing cost transformation and a shift to a lower-risk B2B supply model, but execution risks and elevated net leverage remain concerns.
FMC Corp. stock underperforms Thursday when compared to competitors
FMC Corp. stock (FMC) fell 4.26% to $13.93 on Thursday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also declined. This drop ended a two-day winning streak for the company's shares.
FMC Corp. stock outperforms competitors on strong trading day
Shares of FMC Corp. (FMC) rose 3.33% to $14.26 on Tuesday, outperforming the broader market. This positive performance occurred during a trading session where the S&P 500 Index and Dow Jones Industrial Average also saw modest gains. The stock's increase ended a two-day losing streak for FMC.
Should FMC’s Governance Changes and Legal Scrutiny Require Action From FMC (FMC) Investors?
FMC Corporation is proposing significant governance changes, including removing supermajority voting and allowing shareholders with 25% of shares to call special meetings, amid an investor law firm investigation into potential securities law violations. These changes, coupled with a review of "strategic options" like a potential sale, suggest increased shareholder influence and a heightened focus on accountability. Investors need to consider these developments in light of the company's financial performance and ongoing market pressures as they assess FMC's future direction.
FMC Corporation (NYSE:FMC) Growth Strategies Drive Market Activities NYSE Composite
FMC Corporation, a global agricultural sciences company, specializes in crop protection products including herbicides, insecticides, and fungicides. The article highlights how FMC's growth strategies are driving its market activities within the NYSE Composite, reflecting sector trends and stock performance fluctuations. It also provides a brief overview of the company's sector and product offerings.
FMC Corp. Stock (ISIN: US3024913036) Faces Headwinds in Agricultural Chemicals Amid Pricing Pressure
FMC Corporation is facing challenges in the agricultural chemicals sector due to weak demand and pricing pressures, with its stock trading around $30. Despite missing revenue estimates, the company reported a significant improvement in net income and beat EPS forecasts, driven by cost controls. Analysts maintain a mixed outlook, with potential upside if market conditions stabilize, and the stock offers an attractive dividend yield for income-focused investors.
FMC SEC Filings - Fmc Corp 10-K, 10-Q, 8-K Forms
This page provides access to FMC Corporation's regulatory filings with the SEC, including 10-K, 10-Q, and 8-K forms, detailing financial conditions, restructuring, and governance. Stock Titan enhances these documents with AI-powered summaries and real-time updates for investors tracking FMC's strategic decisions. Recent filings include insider stock purchases and sales, a Q3 loss due to India divestiture charges, and leadership changes.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at J.P. Morgan Industrials Conference
FMC Corporation's Chairman and CEO, Pierre Brondeau, and EVP & CFO, Andrew Sandifer, are scheduled to speak at the J.P. Morgan Industrials Conference on March 18, 2026, at 10:05 a.m. ET. A live webcast of their presentation will be available for investors. The article also provides a market reality check for FMC stock, noting its current trading price significantly below its 200-day moving average and 52-week high, and categorizes the AI impact as neutral.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at J.P. Morgan Industrials Conference
FMC Corporation announced that CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the J.P. Morgan Industrials conference on March 18, 2026, at 10:05 a.m. Eastern Time. A live webcast of their presentation will be available for interested parties. FMC Corporation is a global agricultural sciences company focused on providing innovative crop protection solutions.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at J.P. Morgan Industrials Conference
FMC Corporation announced that its CEO, Pierre Brondeau, and CFO, Andrew Sandifer, will speak at the J.P. Morgan Industrials conference on March 18, 2026, at 10:05 a.m. Eastern Time. A live webcast of their presentation will be available for investors. FMC Corporation is a global agricultural sciences company focused on innovative crop protection solutions.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at J.P. Morgan Industrials Conference
FMC Corporation announced that its CEO, Pierre Brondeau, and CFO, Andrew Sandifer, will be speaking at the J.P. Morgan Industrials conference on March 18, 2026, at 10:05 a.m. Eastern Time. A live webcast of their presentation will be available on the company's investor relations website. FMC Corporation is a global agricultural sciences company providing crop protection solutions.
Biopesticides Gaining Momentum: BASF, Corteva, and FMC Signal a New Era for Biologicals
The biopesticide market is entering a new phase of growth, with sales projected to reach $15 billion to $16 billion by 2029. Major players like BASF and Corteva are making significant investments through acquisitions and product launches, signaling a shift towards integrating biologicals into mainstream crop protection. FMC is focusing on EPA-registered biopesticides that complement synthetic chemistries, emphasizing performance and return-on-investment over replacement.
Michael Barry Buys 18,072 Shares of FMC (NYSE:FMC) Stock
FMC Director Michael Barry recently purchased 18,072 shares of the company's stock for approximately $249,936, significantly increasing his holdings. This insider buying comes as FMC reported disappointing quarterly earnings, missing analyst estimates, and issued lower-than-expected guidance for 2026. Despite a declared quarterly dividend, the stock has experienced downgrades from several brokerages and has an average "Reduce" rating from analysts.
